Industry Research Reports
Home > Reports > Service & Software > Global Clinical Reference Laboratory Molecular Diagnostic Services Market Insights, Forecast to 2031
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Insights, Forecast to 2031
Industry: Service & Software
Published Date: 2025-04-13
Pages: 150 Pages
Report ld: 4707112
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Clinical Reference Laboratory Molecular Diagnostic Services Market Size(US$)
CAGR 2025-2031
5.8%
Market Size,2031
USD 9,639
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,876 million
Market Forecast in 2031(Value)
US$ 9,639 million
CAGR
5.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 9639 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Clinical reference laboratory molecular diagnostic services refer to the analysis of biological samples (such as blood, tissue, etc.) of patients through molecular biology techniques (such as PCR, gene sequencing, etc.) to detect genetic material (DNA, RNA) changes related to diseases, thereby providing scientific basis for disease diagnosis, treatment, and prognosis. Its application areas include disease diagnosis, drug development, personalized medicine, forensic identification, etc.
In recent years, the market size of clinical reference laboratory molecular diagnostic services has been continuously growing. The main driving factors include the application of new technologies such as high-throughput sequencing and digital PCR, the gradual popularization of personalized medicine, the increasing demand for diagnostic testing services, and policy support from governments around the world. In the global market, international giants such as Quest Diagnostics, Eurofins Scientific, and Genomic Health. In the Chinese market, local enterprises such as BGI Genomics and Daan Genomics have gradually enhanced their competitiveness through technological innovation and market expansion. In the future, the development trend of the market lies in intelligence and automation, multi omics integration, remote healthcare, and home testing. Specifically, the laboratory will introduce more automated equipment and artificial intelligence technology to improve detection efficiency and accuracy, while combining genomic, proteomic, and metabolomic data to provide a more comprehensive disease diagnosis plan. With the popularization of technology, molecular diagnostic services will be extended to households and communities to meet the needs of more scenarios.
In terms of production side, this report researches the Clinical Reference Laboratory Molecular Diagnostic Services production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Clinical Reference Laboratory Molecular Diagnostic Services by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Clinical Reference Laboratory Molecular Diagnostic Services, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Clinical Reference Laboratory Molecular Diagnostic Services, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Clinical Reference Laboratory Molecular Diagnostic Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Reference Laboratory Molecular Diagnostic Services sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Clinical Reference Laboratory Molecular Diagnostic Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Clinical Reference Laboratory Molecular Diagnostic Services sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Quest Diagnostics, Eurofins Scientific, Mayo Clinic Laboratories, Genomic Health, Clinical Reference Laboratory, Molecular Pathology Laboratory Network, Opko Health, NantHealth, ARUP Laboratories, Viant Medical, etc.
MARKET SEGMENTATION
By Company
- Quest Diagnostics
- Eurofins Scientific
- Mayo Clinic Laboratories
- Genomic Health
- Clinical Reference Laboratory
- Molecular Pathology Laboratory Network
- Opko Health
- NantHealth
- ARUP Laboratories
- Viant Medical
- Sonic Healthcare
- Fulgent Genetics
- Laboratory Corporation of America Holdings
- BGI Genomics
- Daan Gene
- Guangdong Hybribio Biotech
- Jiangsu Bioperfectus Technologies
- Maccura Biotechnology
- Guangzhou Wondfo Biotech
- GoBroad Healthcare
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Nucleic Acid Amplification Testing
- Nucleic Acid Hybridization Testing
- Gene Sequencing
- Gene Chip Technology
- Others
Segment by Application
- Disease Diagnosis
- Drug Development
- Personalized Healthcare
- Medicolegal Expertise
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Clinical Reference Laboratory Molecular Diagnostic Services production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Clinical Reference Laboratory Molecular Diagnostic Services in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Clinical Reference Laboratory Molecular Diagnostic Services manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Reference Laboratory Molecular Diagnostic Services sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nucleic Acid Amplification Testing
1.2.3 Nucleic Acid Hybridization Testing
1.2.4 Gene Sequencing
1.2.5 Gene Chip Technology
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Disease Diagnosis
1.3.3 Drug Development
1.3.4 Personalized Healthcare
1.3.5 Medicolegal Expertise
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Perspective (2020-2031)
2.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Growth Trends by Region
2.2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2020-2031)
2.3 Clinical Reference Laboratory Molecular Diagnostic Services Market Dynamics
2.3.1 Clinical Reference Laboratory Molecular Diagnostic Services Industry Trends
2.3.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
2.3.3 Clinical Reference Laboratory Molecular Diagnostic Services Market Challenges
2.3.4 Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Reference Laboratory Molecular Diagnostic Services by Players
3.1.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Players (2020-2025)
3.1.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
3.5 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services Head office and Area Served
3.6 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
3.7 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Type (2020-2025)
4.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Application (2020-2025)
5.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2031)
6.2.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031)
6.3.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2031)
7.2.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031)
7.3.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2031)
8.2.2 China Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031)
8.3.2 China Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2031)
9.2.2 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031)
9.3.2 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.1.4 Quest Diagnostics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.1.5 Quest Diagnostics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.2.4 Eurofins Scientific Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Mayo Clinic Laboratories
11.3.1 Mayo Clinic Laboratories Company Details
11.3.2 Mayo Clinic Laboratories Business Overview
11.3.3 Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.3.4 Mayo Clinic Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.3.5 Mayo Clinic Laboratories Recent Development
11.4 Genomic Health
11.4.1 Genomic Health Company Details
11.4.2 Genomic Health Business Overview
11.4.3 Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.4.4 Genomic Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.4.5 Genomic Health Recent Development
11.5 Clinical Reference Laboratory
11.5.1 Clinical Reference Laboratory Company Details
11.5.2 Clinical Reference Laboratory Business Overview
11.5.3 Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.5.4 Clinical Reference Laboratory Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.5.5 Clinical Reference Laboratory Recent Development
11.6 Molecular Pathology Laboratory Network
11.6.1 Molecular Pathology Laboratory Network Company Details
11.6.2 Molecular Pathology Laboratory Network Business Overview
11.6.3 Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.6.4 Molecular Pathology Laboratory Network Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.6.5 Molecular Pathology Laboratory Network Recent Development
11.7 Opko Health
11.7.1 Opko Health Company Details
11.7.2 Opko Health Business Overview
11.7.3 Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.7.4 Opko Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.7.5 Opko Health Recent Development
11.8 NantHealth
11.8.1 NantHealth Company Details
11.8.2 NantHealth Business Overview
11.8.3 NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.8.4 NantHealth Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.8.5 NantHealth Recent Development
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Details
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.9.4 ARUP Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.9.5 ARUP Laboratories Recent Development
11.10 Viant Medical
11.10.1 Viant Medical Company Details
11.10.2 Viant Medical Business Overview
11.10.3 Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.10.4 Viant Medical Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.10.5 Viant Medical Recent Development
11.11 Sonic Healthcare
11.11.1 Sonic Healthcare Company Details
11.11.2 Sonic Healthcare Business Overview
11.11.3 Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.11.4 Sonic Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.11.5 Sonic Healthcare Recent Development
11.12 Fulgent Genetics
11.12.1 Fulgent Genetics Company Details
11.12.2 Fulgent Genetics Business Overview
11.12.3 Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.12.4 Fulgent Genetics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.12.5 Fulgent Genetics Recent Development
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Details
11.13.2 Laboratory Corporation of America Holdings Business Overview
11.13.3 Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.13.4 Laboratory Corporation of America Holdings Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.13.5 Laboratory Corporation of America Holdings Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Details
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.14.4 BGI Genomics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.14.5 BGI Genomics Recent Development
11.15 Daan Gene
11.15.1 Daan Gene Company Details
11.15.2 Daan Gene Business Overview
11.15.3 Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.15.4 Daan Gene Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.15.5 Daan Gene Recent Development
11.16 Guangdong Hybribio Biotech
11.16.1 Guangdong Hybribio Biotech Company Details
11.16.2 Guangdong Hybribio Biotech Business Overview
11.16.3 Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.16.4 Guangdong Hybribio Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.16.5 Guangdong Hybribio Biotech Recent Development
11.17 Jiangsu Bioperfectus Technologies
11.17.1 Jiangsu Bioperfectus Technologies Company Details
11.17.2 Jiangsu Bioperfectus Technologies Business Overview
11.17.3 Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.17.4 Jiangsu Bioperfectus Technologies Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.17.5 Jiangsu Bioperfectus Technologies Recent Development
11.18 Maccura Biotechnology
11.18.1 Maccura Biotechnology Company Details
11.18.2 Maccura Biotechnology Business Overview
11.18.3 Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.18.4 Maccura Biotechnology Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.18.5 Maccura Biotechnology Recent Development
11.19 Guangzhou Wondfo Biotech
11.19.1 Guangzhou Wondfo Biotech Company Details
11.19.2 Guangzhou Wondfo Biotech Business Overview
11.19.3 Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.19.4 Guangzhou Wondfo Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.19.5 Guangzhou Wondfo Biotech Recent Development
11.20 GoBroad Healthcare
11.20.1 GoBroad Healthcare Company Details
11.20.2 GoBroad Healthcare Business Overview
11.20.3 GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.20.4 GoBroad Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.20.5 GoBroad Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nucleic Acid Amplification Testing
Table 3. Key Players of Nucleic Acid Hybridization Testing
Table 4. Key Players of Gene Sequencing
Table 5. Key Players of Gene Chip Technology
Table 6. Key Players of Others
Table 7. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Market Size by Region (2020-2031) & (US$ Million)
Table 10. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region (2020-2031)
Table 11. Market Trends
Table 12. Market Drivers
Table 13. Market Challenges
Table 14. Market Restraints
Table 15. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players (2020-2025)
Table 17. Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Reference Laboratory Molecular Diagnostic Services as of 2024)
Table 18. Global Clinical Reference Laboratory Molecular Diagnostic Services Industry Ranking 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Headquarters and Area Served
Table 21. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
Table 22. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2020-2025)
Table 26. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2026-2031)
Table 28. Global Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2020-2025)
Table 30. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2026-2031)
Table 32. North America Market Size by Type (2020-2031) & (US$ Million)
Table 33. North America Market Size by Application (2020-2031) & (US$ Million)
Table 34. North America Clinical Reference Laboratory Molecular Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Market Size by Country (2020-2031) & (US$ Million)
Table 36. Europe Market Size by Type (2020-2031) & (US$ Million)
Table 37. Europe Market Size by Application (2020-2031) & (US$ Million)
Table 38. Europe Clinical Reference Laboratory Molecular Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Market Size by Country (2020-2025) & (US$ Million)
Table 40. China Market Size by Type (2020-2031) & (US$ Million)
Table 41. China Market Size by Application (2020-2031) & (US$ Million)
Table 42. Asia Market Size by Type (2020-2031) & (US$ Million)
Table 43. Asia Market Size by Application (2020-2025) & (US$ Million)
Table 44. Asia Clinical Reference Laboratory Molecular Diagnostic Services Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 45. Asia Market Size by Region (2020-2031) & (US$ Million)
Table 46. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
Table 47. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
Table 48. Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
Table 50. Quest Diagnostics Company Details
Table 51. Quest Diagnostics Business Overview
Table 52. Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 53. Quest Diagnostics Revenue (2020-2025) & (US$ Million)
Table 54. Quest Diagnostics Recent Development
Table 55. Eurofins Scientific Company Details
Table 56. Eurofins Scientific Business Overview
Table 57. Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 58. Eurofins Scientific Revenue (2020-2025) & (US$ Million)
Table 59. Eurofins Scientific Recent Development
Table 60. Mayo Clinic Laboratories Company Details
Table 61. Mayo Clinic Laboratories Business Overview
Table 62. Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 63. Mayo Clinic Laboratories Revenue (2020-2025) & (US$ Million)
Table 64. Mayo Clinic Laboratories Recent Development
Table 65. Genomic Health Company Details
Table 66. Genomic Health Business Overview
Table 67. Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 68. Genomic Health Revenue (2020-2025) & (US$ Million)
Table 69. Genomic Health Recent Development
Table 70. Clinical Reference Laboratory Company Details
Table 71. Clinical Reference Laboratory Business Overview
Table 72. Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 73. Clinical Reference Laboratory Revenue (2020-2025) & (US$ Million)
Table 74. Clinical Reference Laboratory Recent Development
Table 75. Molecular Pathology Laboratory Network Company Details
Table 76. Molecular Pathology Laboratory Network Business Overview
Table 77. Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 78. Molecular Pathology Laboratory Network Revenue (2020-2025) & (US$ Million)
Table 79. Molecular Pathology Laboratory Network Recent Development
Table 80. Opko Health Company Details
Table 81. Opko Health Business Overview
Table 82. Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 83. Opko Health Revenue (2020-2025) & (US$ Million)
Table 84. Opko Health Recent Development
Table 85. NantHealth Company Details
Table 86. NantHealth Business Overview
Table 87. NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 88. NantHealth Revenue (2020-2025) & (US$ Million)
Table 89. NantHealth Recent Development
Table 90. ARUP Laboratories Company Details
Table 91. ARUP Laboratories Business Overview
Table 92. ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 93. ARUP Laboratories Revenue (2020-2025) & (US$ Million)
Table 94. ARUP Laboratories Recent Development
Table 95. Viant Medical Company Details
Table 96. Viant Medical Business Overview
Table 97. Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 98. Viant Medical Revenue (2020-2025) & (US$ Million)
Table 99. Viant Medical Recent Development
Table 100. Sonic Healthcare Company Details
Table 101. Sonic Healthcare Business Overview
Table 102. Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 103. Sonic Healthcare Revenue (2020-2025) & (US$ Million)
Table 104. Sonic Healthcare Recent Development
Table 105. Fulgent Genetics Company Details
Table 106. Fulgent Genetics Business Overview
Table 107. Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 108. Fulgent Genetics Revenue (2020-2025) & (US$ Million)
Table 109. Fulgent Genetics Recent Development
Table 110. Laboratory Corporation of America Holdings Company Details
Table 111. Laboratory Corporation of America Holdings Business Overview
Table 112. Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 113. Laboratory Corporation of America Holdings Revenue (2020-2025) & (US$ Million)
Table 114. Laboratory Corporation of America Holdings Recent Development
Table 115. BGI Genomics Company Details
Table 116. BGI Genomics Business Overview
Table 117. BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 118. BGI Genomics Revenue (2020-2025) & (US$ Million)
Table 119. BGI Genomics Recent Development
Table 120. Daan Gene Company Details
Table 121. Daan Gene Business Overview
Table 122. Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 123. Daan Gene Revenue (2020-2025) & (US$ Million)
Table 124. Daan Gene Recent Development
Table 125. Guangdong Hybribio Biotech Company Details
Table 126. Guangdong Hybribio Biotech Business Overview
Table 127. Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 128. Guangdong Hybribio Biotech Revenue (2020-2025) & (US$ Million)
Table 129. Guangdong Hybribio Biotech Recent Development
Table 130. Jiangsu Bioperfectus Technologies Company Details
Table 131. Jiangsu Bioperfectus Technologies Business Overview
Table 132. Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 133. Jiangsu Bioperfectus Technologies Revenue (2020-2025) & (US$ Million)
Table 134. Jiangsu Bioperfectus Technologies Recent Development
Table 135. Maccura Biotechnology Company Details
Table 136. Maccura Biotechnology Business Overview
Table 137. Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 138. Maccura Biotechnology Revenue (2020-2025) & (US$ Million)
Table 139. Maccura Biotechnology Recent Development
Table 140. Guangzhou Wondfo Biotech Company Details
Table 141. Guangzhou Wondfo Biotech Business Overview
Table 142. Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 143. Guangzhou Wondfo Biotech Revenue (2020-2025) & (US$ Million)
Table 144. Guangzhou Wondfo Biotech Recent Development
Table 145. GoBroad Healthcare Company Details
Table 146. GoBroad Healthcare Business Overview
Table 147. GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 148. GoBroad Healthcare Revenue (2020-2025) & (US$ Million)
Table 149. GoBroad Healthcare Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 2. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type: 2024 VS 2031
Figure 3. Nucleic Acid Amplification Testing Features
Figure 4. Nucleic Acid Hybridization Testing Features
Figure 5. Gene Sequencing Features
Figure 6. Gene Chip Technology Features
Figure 7. Others Features
Figure 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application: 2024 VS 2031
Figure 10. Disease Diagnosis Case Studies
Figure 11. Drug Development Case Studies
Figure 12. Personalized Healthcare Case Studies
Figure 13. Medicolegal Expertise Case Studies
Figure 14. Others Case Studies
Figure 15. Clinical Reference Laboratory Molecular Diagnostic Services Report Years Considered
Figure 16. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region: 2024 VS 2031
Figure 19. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players in 2024
Figure 20. Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Reference Laboratory Molecular Diagnostic Services as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
Figure 22. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
Figure 24. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
Figure 25. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 26. United States Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
Figure 30. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
Figure 31. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 32. Germany Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Nordic Countries Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. China Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. China Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
Figure 40. China Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
Figure 41. Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
Figure 43. Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
Figure 44. Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region (2020-2031)
Figure 45. Japan Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South Korea Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. China Taiwan Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. India Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Australia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2031)
Figure 53. Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2031)
Figure 54. Middle East, Africa, and Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 55. Brazil Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Mexico Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Turkey Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Israel Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. GCC Countries Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 61. Quest Diagnostics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 62. Eurofins Scientific Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 63. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 64. Genomic Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 65. Clinical Reference Laboratory Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 66. Molecular Pathology Laboratory Network Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 67. Opko Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 68. NantHealth Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 69. ARUP Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 70. Viant Medical Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 71. Sonic Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 72. Fulgent Genetics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 73. Laboratory Corporation of America Holdings Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 74. BGI Genomics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 75. Daan Gene Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 76. Guangdong Hybribio Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 77. Jiangsu Bioperfectus Technologies Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 78. Maccura Biotechnology Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 79. Guangzhou Wondfo Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 80. GoBroad Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Clinical Reference Laboratory Molecular Diagnostic Services market?
The top companies in the global Clinical Reference Laboratory Molecular Diagnostic Services market are Quest Diagnostics、Eurofins Scientific、Mayo Clinic Laboratories.
What is the annual compound growth rate of the global Clinical Reference Laboratory Molecular Diagnostic Services market size from 2025 to 2031?
What was the global market size of Clinical Reference Laboratory Molecular Diagnostic Services in 2031?
What was the global market size of Clinical Reference Laboratory Molecular Diagnostic Services in 2025?
Which region is expected to have the highest market share?
Related Reports
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 10140 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 150
USD 4900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2026
The global Clinical Reference Laboratory Molecular Diagnostic Services market was valued at US$ 6876 million in 2025 and is anticipated to reach US$ 10140 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 131
USD 2900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6876 million in 2025 and is forecast to reach a readjusted size of US$ 10140 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6876 million in 2025 and is projected to reach US$ 10140 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 140
USD 3950.00
(Single User License)
Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 128
USD 3950.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 9639 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-04-13
Pages: 92
USD 2900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 103
USD 4250.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 10140 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 150
USD 4900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2026
The global Clinical Reference Laboratory Molecular Diagnostic Services market was valued at US$ 6876 million in 2025 and is anticipated to reach US$ 10140 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 131
USD 2900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6876 million in 2025 and is forecast to reach a readjusted size of US$ 10140 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 (Single User License)Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6876 million in 2025 and is projected to reach US$ 10140 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 140
USD 3950.00 (Single User License)Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 128
USD 3950.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 9639 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-04-13
Pages: 92
USD 2900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 103
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now